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M any strategies of lung procurement are currentlyused worldwide, with no consensus regarding
which is the most effective.1 Safe graft ischemic times
are generally considered to be around 6 to 8 hours irre-
spective of which technique is used, suggesting that
none is superior to the others for short-term preservation
of good-quality donor organs. Much experimental work
has addressed this issue in the hope that a procurement
technique might evolve that provides such satisfactory
graft preservation as that experienced in liver and kidney
transplantation. A modest reduction in lung graft failure
and early mortality rates caused by ischemia-reperfusion
injury would exert a significant effect on overall long-
term survivals, particularly in the absence of an immi-
nent treatment modality for bronchiolitis obliterans.
Objectives: The perfect strategy for pulmonary graft preservation
remains elusive. Experimental work supports the use of perfusates, such
as Euro-Collins, University of Wisconsin, and low-potassium dextran
solutions. We use low-potassium dextran solution in our clinical pro-
gram, but we aim for continued improvement. The trisaccharide raffi-
nose has been shown to be responsible for the efficacy of University of
Wisconsin perfusate in lung preservation. Raffinose is superior to a
variety of other saccharides for this purpose. We tested the hypothesis
that the addition of raffinose to low-potassium dextran solution might
further improve graft function. Methods: In a randomized blinded study
with a rat left lung transplant model, donor lungs were flushed with
either standard low-potassium dextran solution or low-potassium dex-
tran solution modified by the addition of 30 mmol/L raffinose (n = 5 for
each group). Alprostadil (prostaglandin E1, 500 µg/L) was added to the
perfusates in accordance with our clinical practice. Grafts were stored
inflated at 4˚C for 24 hours. After transplantation, recipients were ven-
tilated with a fraction of inspired oxygen of 1 and a positive end-expira-
tory pressure of 2 cm H2O. Graft function was evaluated by measuring
oxygenation at 2 hours after graft reperfusion, peak airway pressure
throughout the reperfusion period, and the wet/dry lung weight ratio.
Results: The group receiving low-potassium dextran solution with raffi-
nose demonstrated significantly higher oxygenation (oxygen tension,
370 ± 45 mm Hg vs 150 ± 64 mm Hg; P = .0025), lower peak airway pres-
sures at 2 hours after lung reperfusion (11 ± 2.7 mm Hg vs 16 ± 2.4 mm
Hg; P < .001), and a lower wet/dry weight ratio (4.7 ± 1.26 vs 11 ± 5.0;
P = .017). Conclusion: Modification of low-potassium dextran solution
with the trisaccharide raffinose resulted in a significant improvement
in graft function in this model and merits further evaluation with
respect to the mechanisms involved. (J Thorac Cardiovasc Surg 2000;
119:488-92)
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Low-potassium dextran (LPD) has been evaluated in
experimental studies thoroughly over the past
decade,2-8 but in a recent worldwide survey of lung pro-
curement practice,1 no center reported its use as a per-
fusate at that time. However, its use in clinical trans-
plantation has now been reported.9 Since obtaining a
license for its clinical use in Canada in early 1998, we
have used LPD in our clinical program in over 50 con-
secutive cases with encouraging results. We strive con-
tinually for further improvement. The ability to pre-
serve with confidence the more marginal lungs could
potentially increase the pool of donors.
The trisaccharide raffinose is included in University
of Wisconsin (UW) solution as an impermeant and has
been shown to be largely responsible for the efficacy of
UW solution as a lung storage medium.10 Furthermore,
raffinose has been shown to be superior to a variety of
other saccharides for this purpose.11 Another study has
documented the efficacy of a simple raffinose solution
by using a porcine paracorporeal model with 24 hours
of ischemia.12 We tested the hypothesis that the addi-
tion of raffinose to LPD enhances its preservation prop-
erties, leading to improved graft function after trans-
plantation of rat lungs after long-term preservation.
Material and methods
Preparation of modified LPD. Raffinose (17.86 g = 30
mmol/L) pentahydrate (Sigma Chemical Co, St Louis, Mo)
was dissolved in 500 mL of LPD solution (Perfadex;
Biophausia, Uppsala, Sweden) at room temperature and then
reintroduced into the bag through a 0.22-µm filter (Millex-
GS; Millipore Corporation, Bedford, Mass). Tromethamine
(INN: trometamol) was added to adjust the pH to 7.5. The
resultant solution was colorless and indistinguishable from
standard LPD solution. This enabled the experiments to be
conducted in a blind fashion. The composition of the 2 solu-
tions evaluated is shown in Table I.
Donor procedure. The Institutional Animal Care and Use
Committee of the Toronto General Hospital reviewed and
approved the protocol for this study. All animals received
humane care in accordance with the “Guide for the care and
use of laboratory animals” (NIH Publication No. 85-23,
revised 1985).
Ten isogeneic Lewis rats (Charles River Inc, Montreal,
Canada) with an average body weight of 337 ± 12.6 g were
anesthetized by means of an intraperitoneal injection of 1 mL
of sodium pentobarbital (Somnotol; MTC Pharmaceuticals,
Cambridge, Canada) and intubated through a tracheostomy
with a 14-gauge intravenous catheter. Animals were connect-
ed to a volume-controlled ventilator (Harvard Rodent
Ventilator, model 683, Harvard Apparatus Co, Inc, S Natick,
mass) and ventilated with a fraction of inspired oxygen of 1,
a tidal volume of 10 mL/kg at 75 breaths/min, and a positive
end-expiratory pressure of 2 cm of H2O. After this, a median
laparosternotomy was performed, and 300 USP of heparin
(Hepalean; Organon Teknika, Toronto, Canada) was injected
into the inferior vena cava. For the retrieval of the heart-lung
block, the inferior vena cava was incised, the left atrial
appendage was truncated, and a 14-gauge cannula was placed
through a right ventricular outflow tractotomy into the main
pulmonary artery. The lungs were flushed through this can-
nula with 20 mL of either LPD or LPD modified with 30
mmol/L raffinose (LPD-R) at 4˚C. The flush solution also
contained 500 µg/L of alprostadil (prostaglandin E1, Prostin
VR; Upjohn, Don Mills, Canada). Immediately after the
lungs had been flushed, the intratracheal tube was clamped to
keep the lungs inflated for the time period of storage, and the
heart-lung block was excised. Care was taken to maintain
hypothermic conditions, during which semirigid cuffs pre-
pared from a 14-gauge cannula were placed into the pul-
monary artery, pulmonary vein, and main bronchus. In each
case the vessel or bronchus was drawn through the center of
the cuff, everted circumferentially around it, and secured with
a 7-0 polypropylene ligature.
Recipient procedure. Recipient animals were anesthetized
and intubated as described for donor animals. Animals’ lungs
were ventilated in a similar fashion. For measuring the airway
pressure during transplantation and after graft reperfusion, a
3-way tap was inserted between the intratracheal tube and the
ventilator circuit and connected to a pressure transducer. The
condition of the recipient was monitored by blood pressure
measurement through a 22-gauge cannula placed in the right
carotid artery. A left-sided thoracotomy was performed
through the 5th intercostal space. The left lung was mobilized
by dividing the pulmonary ligament. A paper clip was placed
on the left lung to facilitate retraction. The hilum of the left
lung was dissected, and the pulmonary artery, pulmonary
vein, and the left main bronchus were identified and isolated.
All 3 structures were clamped by using microsurgical
aneurysm clamps. All 3 structures were incised on their ante-
rior aspect, and the 3 cuffs of the donor lung were placed into
the equivalent recipient structures and fixed with a 7-0
polypropylene suture. After a standardized total warm
ischemic time of 30 minutes, the transplanted lung was inflat-
ed, and blood was reintroduced by releasing the pulmonary
vein followed by the arterial clamps. A 19-gauge drainage
Table I. Composition of flush solutions
Component LPD LPD-R
Dextran 40 50 g/L 50 g/L
NaCl 8 g/L 8 g/L
KCl 400 mg/L 400 mg/L
MgSO4 98 mg/L 98 mg/L
Na2HPO4 46 mg/L 46 mg/L
KHPO4 63 mg/L 63 mg/L
Glucose 910 mg/L 910 mg/L
Raffinose pentahydrate — 17.86 g/L
Tromethamine 0.144 g/L 0.144 g/L
Osmolarity (measured) 292 mmol/L 306 mmol/L
pH 7.5 7.5
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catheter (Butterfly-19; Abbott Laboratories Ltd, Saint
Laurent, Canada) was placed into the left pleural space to
avoid accumulation of fluid in the chest. The thoracotomy
was closed loosely, and the recipient animal was ventilated
with 100% oxygen at a rate of 75 breaths/min, a tidal volume
of 10 mL/kg, and a positive end-expiratory pressure of 2 cm
H2O for 2 hours.
Graft assessment. Recipient arterial blood pressure was
measured continuously and recorded at 15-minute intervals.
Peak airway pressure was recorded before reperfusion; at 1,
5, and 15 minutes after reperfusion; and then every 15 min-
utes thereafter. Oxygenation of graft venous blood was
assessed at the end of the 2-hour reperfusion period. Blood
was sampled under direct vision by using a heparinized nee-
dle inserted distal to the anastomotic cuff and directed toward
the donor lung. After 2 hours, the donor lung was excised,
weighed, and desiccated to constant weight at 100˚C. The
wet/dry weight ratio was determined.
Statistical analysis. All data are expressed as mean values
± SD. An unpaired, 2-tailed, Student t test analysis was used
to determine statistical significance between the 2 study
groups regarding the blood gas data and the wet/dry graft
weight ratio. To evaluate statistical difference between groups
regarding the peak airway pressures over the 2-hour reperfu-
sion period, a 2-way analysis of variance (ANOVA) for
repeated measure was used. The SigmaStat version 1.0
(Jandel Scientific, San Rafael, Calif) software package was
used for all statistical analyses.
Results
There were no statistically significant differences in
donor or recipient body weights (P = .12 for the LPD-
R group and P = .09 for the LPD group). There were
also no differences in the systolic arterial blood pres-
sures of the recipients throughout the assessment peri-
od, as determined by using a rank-sum test (P = .103).
Oxygenation 2 hours after graft reperfusion was sig-
nificantly higher in the LPD-R group (370 ± 45 mm
Hg vs 150 ± 67 mm Hg; P = .0025, Student t test).
Pulmonary edema causes increased airway resistance,
which is reflected in changes in peak airway pressures
over the entire graft reperfusion period. Peak airway
pressures differed significantly overall between groups
(P = .012), as determined by using a 2-way ANOVA.
Using the Newman-Student-Keuls test, we found that
only at 2 hours after graft reperfusion were the differ-
ences between groups statistically significant (P <
.001; 11 ± 2.7 mm Hg for the LPD-R group vs 16 ± 2.4
mm Hg for the LPD group, as shown in Fig 1). The
increase in edematous fluid contained in the graft after
reperfusion reflects the severity of lung injury. The
wet/dry graft weight ratio was significantly lower in
the LPD-R group at the end of the reperfusion period
(4.7 ± 1.26 vs 11 ± 5.0; P = .017, Student t test). All
data met normality and equal variance conditions,
except the systolic arterial blood pressure data.
Therefore those were analyzed by using a rank-sum
test.
Discussion
In the pursuit of continued improvements in lung
preservation, many models have been developed.13,14
Small animal models offer the advantage of lower cost
and therefore the ability to screen different regimens of
preservation before further evaluation in larger species.
One disadvantage of using a small animal is the possi-
ble confounding factor of anastomotic variability in
influencing the results. In this model the technique of
semirigid connecting cuffs for all the anastomoses
enables the possibility of variability in anastomoses to
be largely discounted. We wished to inflict a major
ischemic injury on the grafts, and therefore a period of
24 hours was chosen. Other studies with the rat had
found 12 and even 6 hours of graft preservation to
cause measurable reductions in graft function after
transplantation, depending on the storage tech-
nique.15,16 Interspecies variation in susceptibility to
ischemia is recognized, possibly because of widely dif-
fering circulating levels of xanthine oxidase,17 and thus
caution is required in interpreting results of differing
ischemic times in different species.
Single lung transplantation is the most commonly
performed procedure for replacement for end-stage
lung disease.18 To evaluate the ability of the transplant-
ed lung to oxygenate blood, we sampled blood directly
Fig 1. Peak airway pressures (PAwP) in millimeters of mer-
cury throughout the 2-hour period of reperfusion. Data points
are expressed as the mean values ± SD. Overall, the 2 groups
differed significantly (P = .012; 2-way ANOVA). However,
the Student-Neuman-Keuls multiple comparison procedure
revealed significant differences in peak airway pressures only
at 120 minutes after graft reperfusion (P < .001) with 11 ± 2.7
mm Hg (LPD-R) versus 16 ± 2.4 mm Hg (LPD).
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from the pulmonary vein of the transplanted lung by
means of needle aspiration distal to the anastomosis
cuff. A concern may be the inadvertent sampling of left
atrial blood. The randomized blind nature of this study
mitigates this as a confounding factor. Repeated sam-
pling throughout the study period would disrupt the
pulmonary vein, and this study is limited by the single
assessment after 2 hours. We chose not to occlude the
hilum of the contralateral native lung for two reasons.
First, in preliminary studies immediate contralateral
hilar ligation often resulted in prompt death of the ani-
mal before any meaningful assessment of the graft
could be carried out. Second, if the animal survives a
few minutes of reperfusion, although reasonable oxy-
genation data might be obtained, the ability of the graft
to adapt and undergo repair is still impossible to assess.
Therefore by avoiding contralateral lung ligation, this
more readily reflects the situation in clinical practice,
and importantly, we were able to reliably assess the
graft after a 2-hour period of reperfusion.
The oxygenation data is impressive; the group
flushed with the LPD-R solution demonstrated clearly
superior function. The actual value of airway pressure
recorded is not an absolute reflection of changes in
compliance of the donor lung. Given that a fixed tidal
volume was used to ventilate both lungs through a sin-
gle-lumen tube, the inevitable decrease in compliance
of the donor lung will result in preferential ventilation
of the native lung. This simply serves to underestimate
the real changes in compliance of the graft. Therefore
the significant difference in airway pressures that
occurred reinforces our hypothesis that the LPD-R
lungs were more compliant. A lower wet/dry weight
ratio of the raffinose-modified group implies less pul-
monary edema and hemorrhage.
Raffinose is a natural trisaccharide that is not found
in human subjects. It is present in leguminous seeds
and is formed from modified sucrose to which a galac-
tose moiety is linked (α-Gal[1-6]α-Glc[1-2]β-Fru).19 It
was included in UW solution by Belzer and Southard20
for its properties as an osmotic impermeant that would
neither diffuse nor be metabolized and thus aid in main-
tenance of the endothelial cell integrity of pancreas and
liver grafts. It has also been used in studies of the renal
proximal convoluted tubule to prevent cellular
swelling.21 UW solution is complex and has been eval-
uated extensively as an alternative to Euro-Collins
solution for lung preservation.15,16 Concern remains
with regard to the high potassium composition of such
a solution and its possible deleterious effect on the pul-
monary endothelium.22,23 One study was able to
demonstrate that the sequential removal of all the com-
ponents of UW solution other than the phosphate
buffers and the raffinose resulted in no reduction in its
efficacy in lung preservation.10 A subsequent study
evaluated raffinose in comparison with iso-osmolar
ionic-equivalent solutions of other saccharrides, such
as melezitose, trehalose, sucrose, fructose, and glucose,
and raffinose was determined to be superior to these.
Trisaccharrides afforded superior graft preservation
compared with disaccharides and monosaccharrides.11
On the basis of this, a simple solution of phosphate-
buffered raffinose has been shown to be as effective as
standard UW solution in a porcine model.12
The mechanisms by which raffinose exerted its
impressive effect in this study are unclear. A concen-
tration of 30 mmol/L was chosen because it had been
used successfully in earlier studies with UW solu-
tion.10,11 We wished to exclude a major change in
osmolarity as a potential cause of changes in graft
function. Addition of raffinose resulted in only a slight
increase in measured osmolarity (Table I), which was
still within the normal physiologic range. We believe
therefore that raffinose has inherent beneficial proper-
ties. The disaccharide trehalose has also been evaluat-
ed by other centers with promising results and has a
sound theoretic basis for its potential role in organ
preservation.24-27 It seems reasonable to suggest that
trehalose may also improve the role of LPD solution.
We have extensively evaluated LPD solutions for
lung preservation. We believe a low potassium concen-
tration to be desirable, as a result of our work and that
of other groups.3,6,7,23 We now use it clinically. Because
many highly active programs are trying to extend donor
organ use to include older and marginal organs, we
believe the issue of lung preservation assumes increas-
ing importance. Normal younger donor organs with rel-
atively short ischemic times of around 6 to 8 hours
appear to function satisfactorily, irrespective of the
choice of perfusate. A recent report, however, docu-
mented increased mortality rates resulting from the
combination of older donors and graft ischemic times
greater than 7 hours.28 However, there is a lack of con-
sensus worldwide. A survey carried out in 1996
revealed that highly active and successful programs
performing in excess of 40 transplants per year were
using Euro-Collins, UW, and Wallwork solutions and
donor core cooling. This implies that neither is obvi-
ously superior to the others for short-term preservation.
However, we strive to improve our current standard in
view of the long ischemic times required to procure
organs across Canada. We envisage the development of
a strategy that will enable rescue of marginal donors.
This study is our first attempt to improve our choice
of perfusate. We are encouraged by our results. The fact
that rat lungs stored for 24 hours are able to function to
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any reasonable degree is an indicator of the efficacy of
LPD alone. In one study rat lungs stored in UW solu-
tion for 24 hours functioned well only if the technique
of controlled low-pressure reperfusion was applied.29
In our model the clamp was simply removed from the
hilum, making this a stringent test of the quality of
preservation. That such an improvement was seen after
the relatively simple modification with raffinose is
remarkable. Ongoing work in our laboratory is now
directed toward elucidating the mechanisms involved.
We thank Dr Peter Lewycky, who reviewed the statistical
analysis, and Dr Joan Mates, Senior Research Technician,
and Mr Bill Kalirai in conducting these experiments.
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